Board Meeting10 Jul 2026, 03:49 pm
Sun Pharma Board Meeting on July 31 for Q1 FY27 Results
AI Summary
Sun Pharmaceutical Industries Ltd has announced that its Board of Directors will convene on July 31, 2026. The primary agenda for this meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. The company also confirmed that the trading window, which was closed from July 1, 2026, will remain shut until August 2, 2026, in accordance with SEBI regulations.
Key Highlights
- Board meeting scheduled for July 31, 2026.
- To approve Unaudited Standalone and Consolidated Financial Results.
- Results are for the quarter ended June 30, 2026.
- Trading window closure extended until August 2, 2026.
Price Impact
More from SUNPHARMA